NEWS

Posted on :

May 19, 2025

Kolosis Announces the Appointment of Tim Larsen as Chief Financial Officer

Kolosis BIO announced today the appointment of Tim Larsen as Chief Financial Officer.

As Chief Financial Officer, Tim is responsible for leading the company’s financial strategy, planning, and infrastructure. He oversees all aspects of finance and accounting, ensuring Kolosis is positioned for scalable, long-term growth.

Tim brings over two decades of executive leadership in finance, operations, and information systems. Before joining Kolosis, he served as COO at Alder Holdings. There, he helped grow the business from a single-entity startup to a $500 million international enterprise spanning software, hardware manufacturing, and global BPO operations. His work included building enterprise-level financial systems and implementing international IT infrastructure to support growth.

Tim holds a bachelor’s degree in accounting from the University of Utah.

About Kolosis BIO:

Kolosis BIO is a leading provider of innovative biologic solutions, dedicated to commercializing cutting-edge technologies and delivering market-leading products to the orthopedic industry. As a pure-play biologics company, Kolosis BIO exclusively partners with MTF Biologics to offer superior quality bone graft technologies such as Kore Fiber, a 100% cortical fiber allograft and Prime HD, a pre-hydrated DBM. These allografts are backed by MTF’s proprietary aseptic processing methods that optimally preserve matrix structures and osteoinductive properties.

As the company looks to the future, Kolosis is dedicated to driving innovation in the biologics field, expanding its product offerings and pushing the boundaries of science to enhance patient outcomes. With a focus on relentless execution and bold technologies, Kolosis BIO endeavors to become a leading force in the biologics market. For more information, please visit www.kolosis.com.

About MTF Biologics:

MTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. They provide unmatched service, resources, and expertise to donors and their loved ones who give the gift of donation, people who depend on tissue and organ transplants, healthcare providers, and clinicians and scientists.

The International Institute for the Advancement of Medicine (IIAM), a Division of MTF Biologics, honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Statline, also a Division of MTF Biologics, provides specialized communications and technology expertise to organ, tissue, and eye procurement organizations, as well as the hospitals and patients that they serve. Its sister organization, Deutsches Institute for Zell-und Gewebeersatz – DIZG (The German Institute for Cell and Tissue Transplantation), expands its reach to patients across the globe. For more information, visit www.mtfbiologics.org.